Pharmaceutical Industry
Germany – A World-Class Pharmaceutical Location
Combining cutting edge-innovation, a long tradition as the “world´s pharmacy” and continuously growing demand for healthcare products, Germany is the ideal location for pharmaceutical R&D, production, and sales of medicines.
Driven by trends such as demographic change, a rise in chronic diseases and an increasing emphasis on prevention and self-medication, Europe’s biggest pharmaceutical market is growing faster than the German economy. Germany belongs to the world’s leading clinical trials locations and - based on R&D investment and patent application levels - is the leading pharmaceutical innovation location in Europe. Building on these competencies, many German organizations have also joined global efforts to combat the Covid-19 pandemic.
The country is the largest exporter of medicinal products and ranks among the top pharmaceutical producers worldwide. In light of the global need for personalized medicine, Germany has also evolved into one of the main suppliers of novel biopharmaceuticals. Located in the heart of Europe and benefiting from excellent infrastructure and a highly skilled workforce, the continent’s most populous country offers attractive opportunities and a favorable investment climate for pharmaceutical companies planning to expand internationally.
